Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis

医学 CD14型 CD86 CD80 川地163 免疫学 甘露糖受体 表型 流式细胞术 巨噬细胞 单核细胞 免疫分型 清道夫受体 川地68 免疫系统 内科学 CD40 生物 T细胞 免疫组织化学 脂蛋白 细胞毒性T细胞 体外 生物化学 胆固醇 基因
作者
Stefano Soldano,Amelia Chiara Trombetta,Paola Contini,Veronica Tomatis,Barbara Ruaro,R. Brizzolara,P. Montagna,Alberto Sulli,Sabrina Paolino,Carmen Pizzorni,Vanessa Smith,Maurizio Cutolo
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:77 (12): 1842-1845 被引量:85
标识
DOI:10.1136/annrheumdis-2018-213648
摘要

Alterations in macrophage polarisation are recognised among the possible immune system abnormalities contributing to systemic sclerosis (SSc) pathogenesis.1 Macrophages have been classified as classically (M1) or alternatively (M2) activated, although growing evidence indicates that they may exhibit characteristics shared by more than one of the described phenotypes.2–5 An M2 pre-eminent phenotype has been postulated for SSc monocytes/macrophages.2 The aim of the study was to widen a phenotype characterisation (M1, M2 and mixed M1/M2) of circulating monocytes/macrophages in patients with SSc and healthy subjects (HSs) through flow cytometry analysis. Fifty-eight consecutive patients with SSc (38 limited and 20 diffuse SSc) and 27 age-matched and gender-matched HSs were enrolled after signing informed consent. SSc diagnosis was based on the 2013 American College of Rheumatology/European League Against Rheumatism criteria (online supplementary file 1).6 For flow cytometry analysis, peripheral blood was collected and anti-CD14 and anti-CD45 antibodies were used to identify the monocyte/macrophage lineage; macrophage scavenger receptors (CD204, CD163) and mannose receptor 1 (CD206) were used as M2 phenotype markers; and co-stimulatory molecules (CD80, CD86) and Toll-like receptors (TLR4, TLR2) were used as M1 phenotype markers. CD66b was used to distinguish granulocytes (Miltenyi Biotech, Germany). Flow  c ytometry analysis was performed using the Navios flow cytometer and Kaluza analysis software (Beckman Coulter). A total of  5 × 10 6 cells were evaluated and more than 30 events were detected in the smallest subset investigated, according to the consensus guidelines for minimal residual disease. Results were expressed in percentages over total circulating leu c ocytes, unless otherwise specified. The non-parametric al Mann-Whitney U test was used for statistical analysis and any p value lower than 0.05 was considered statistically significant.  Two initial gating strategies were used to study circulating M2-like monocytes/macrophages, the first gated CD14+cells and the second gated CD204 …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lbx完成签到,获得积分10
1秒前
积极钧完成签到,获得积分10
4秒前
Ammr完成签到 ,获得积分10
6秒前
贰鸟完成签到,获得积分0
6秒前
顾矜应助沈沈采纳,获得10
9秒前
QOP应助NXK采纳,获得10
14秒前
雁塔完成签到 ,获得积分10
15秒前
安安完成签到 ,获得积分10
15秒前
Mark完成签到 ,获得积分10
15秒前
lynn完成签到 ,获得积分10
18秒前
hh完成签到 ,获得积分10
18秒前
热心不凡完成签到,获得积分10
19秒前
LRxxx完成签到 ,获得积分10
25秒前
28秒前
苗苗完成签到,获得积分10
37秒前
奋斗跳跳糖完成签到,获得积分10
39秒前
彩色完成签到 ,获得积分10
40秒前
CipherSage应助科研通管家采纳,获得10
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
suibianba应助科研通管家采纳,获得10
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
FashionBoy应助科研通管家采纳,获得10
47秒前
科研通AI2S应助科研通管家采纳,获得10
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
cdercder应助科研通管家采纳,获得30
47秒前
劲秉应助科研通管家采纳,获得10
47秒前
合适的寄灵完成签到 ,获得积分10
48秒前
HY完成签到,获得积分10
49秒前
斯文的难破完成签到 ,获得积分10
50秒前
123完成签到 ,获得积分10
56秒前
彩色的涵柳完成签到,获得积分20
57秒前
从容芮应助lambda采纳,获得200
1分钟前
她的城完成签到,获得积分0
1分钟前
鹏gg完成签到 ,获得积分10
1分钟前
居居侠完成签到 ,获得积分10
1分钟前
懵懂的毛豆完成签到,获得积分10
1分钟前
晨曦完成签到 ,获得积分10
1分钟前
Gary完成签到 ,获得积分10
1分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
Genre and Graduate-Level Research Writing 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3674499
求助须知:如何正确求助?哪些是违规求助? 3229813
关于积分的说明 9787137
捐赠科研通 2940387
什么是DOI,文献DOI怎么找? 1611904
邀请新用户注册赠送积分活动 761060
科研通“疑难数据库(出版商)”最低求助积分说明 736471